NEWS Latest News July 28, 2022 Nilogen Oncosystems Announces Opening of Clinical Trial Using Ex Vivo Tumoroids to Predict Immunotherapy Response in Non-Small Cell Lung Cancer (TUMORIN) July 12, 2022 Nilogen Oncosystems Announces Partnership with Scailyte AG to Provide Clinically Relevant Translational Platform Supporting Development of Immuno-Oncology Therapeutics in Oncology Clinical Trials July 1, 2021 Nilogen Oncosystems announces the appointment of Eolas Biosciences as its exclusive business partner in Japan for marketing the 3D-EXplore tumoroid platform April 1, 2021 Nilogen to publish 3 new posters at AACR 2021 January 20, 2021 Nilogen expands its business development and translational team Load More ASK US A QUESTION We’re here to answer any questions you have about our work, services and more. Contact Us
